Back to catalogue
№ 107 36 filings · 2021-10-04 → 2026-09-14

CERILLION PLC

CER
Technology Share price 672p Market cap £201m Overall fit 605 /1000

Strong fit on operating leverage, downside protection and (post de-rating) valuation discipline, but only modest alignment with the AI-receiver pillar — Cerillion embeds AI agents in its BSS/OSS platform but is not a direct AI picks-and-shovels name. The 60% share-price drop since mid-2026 has created a genuinely interesting valuation entry point for a high-margin, net-cash software franchise.

Fair value range 900p–1,170p Mid case · £305m
Absolute upside +51.4% vs current market cap
Conviction 3/5 confidence in undervalued call
Supports the call
  • Clean, consistent five-year financial record with transparent definitions
  • Record £82.1m back-order book provides tangible near-term revenue floor
  • Durable high-margin software economics make mid-cycle normalisation defensible
Limits the call
  • FY26 profit warning changes trajectory; cannot verify whether deferred orders return
  • Telco customer spending behaviour in FY27 is the critical swing factor with limited visibility
Methodology

Mid-cycle EV/EBITDA (10-12x) and normalised P/E (18-20x), cross-checked, adding £32m net cash

In one line · bull case

Post-profit-warning entry point into a 50%-EBITDA-margin, net-cash telco software franchise with a record back-order book and operating leverage that will work in reverse if deferred orders convert.

In one line · biggest risk

The deferred orders may represent competitive losses or structural telco spending restraint rather than timing slips, in which case the FY25 margin peak was the cycle high.

Drivers
AI beneficiary 45 /100
Vertical SaaS embedding AI Agents and MCP server in telco BSS/OSS platform — partial beneficiary but AI is not the dominant revenue driver.
Operating leverage 85 /100
Textbook high: 80%+ gross margin software, fixed R&D and central costs, demonstrated 1,320bps margin swings on 14% revenue moves.
Earnings vs expectations 55 /100
Five consecutive annual beats FY21-FY25, broken by a material September 2026 miss — net pattern now mixed.
Growth momentum 40 /100
Decelerated from +25% in FY21/FY22 to roughly flat in FY26; back-order book suggests potential recovery but timing uncertain.
Moat 65 /100
Deeply embedded in telco operations, high switching costs, product-centric differentiation vs bespoke rivals, but not a dominant global brand.
Earnings quality 80 /100
Unqualified audit reports, strong historical cash conversion, modest capitalisation of development costs; adjustments limited to small share-based payment charges.
Management quality 70 /100
Founder-led (CEO Louis Hall since 1999), consistent capital returns, candid disclosure in profit warning; CEO sold £20m stake just before de-rating is a minor negative.
Cyclicality 35 /100
Mission-critical telco software with mostly recurring revenue, but licence revenue timing creates period volatility.
Leverage 10 /100
Net cash £32.5m, zero material debt — fortress balance sheet.
Value-trap signals · 2
  • First meaningful profit warning in the company's post-IPO history
  • CEO sold £20m of stock at 1,500p three months before the de-rating began

Cerillion PLC (CER) — Investment Research Note

Executive summary

Cerillion is a specialised UK-listed BSS/OSS software vendor selling billing, charging and CRM platforms to telecoms operators (c.70 customers in c.45 countries), with a product-centric SaaS model that stands apart from the services-heavy, bespoke incumbents. Over FY20–FY25 revenue roughly doubled from £20.8m to £45.4m while adjusted EBITDA margin expanded from 27.9% to a remarkable 50.9%, driven by increasing software-licence mix and operating leverage; however, FY26 has disappointed, with a 14 Sep 2026 profit warning cutting revenue guidance to £46–48m (vs. consensus £52.8m) and EBITDA margin to 43–45% (vs. 45.2%) as licence orders and expansions slipped. The single most important point for valuation today is whether those orders are genuinely deferred — in which case the record £82.1m back-order book, £271m pipeline and 50%-margin software licence model make the de-rated shares cheap — or whether this is the start of a structural slowdown.

Fair value estimate

  • Methodology: mid-cycle normalised earnings multiple cross-checked with EV/EBITDA, anchored to the £82.1m back-order book and £32.5m net-cash balance.
  • Key assumptions: FY27 revenue recovers to £50–55m (back-order book conversion plus modest new licence recognition); EBITDA margin reverts toward 46–48% (vs. H1 2026 trough of 34.5% and FY25 peak of 50.9%); valued at 10–12x EV/EBITDA (reasonable for scaled vertical SaaS with net cash) and 18–20x normalised earnings.
  • Mid-cycle EBITDA: £23–26m → EV range £230m–£312m + £32m net cash → £262m–£344m equity.
  • Fair value range: 900p – 1,170p per share (implied market cap £265m – £345m).
  • Mid-point fair value: ~1,035p / ~£305m market cap.
  • Vs. current £206.8m market cap at 670p → absolute upside ~55% to the mid-point (34% to the low end, 75% to the high).

Sector context

  • Sector: Technology — Software, specifically vertical B2B SaaS for telecoms (BSS/OSS category).
  • Quality profile: well above typical peers — gross margins ~80%, adjusted EBITDA margin 50.9% at FY25 peak, net cash, mid-single-digit to mid-teens growth. The business is capital-light, with ~70% recurring/subscription-adjacent revenue and multi-year customer tenure. 2025-11 final results
  • Listed peers: Amdocs (NASDAQ:DOX) and CSG Systems (NASDAQ:CSGS) are the obvious scaled telecoms BSS peers; closer-size UK comparables include Beeks Financial Cloud and GB Group (not perfect fits — few UK-listed vertical-SaaS peers of similar scale).

Investment thesis

  1. Record back-order book and pipeline underpin a plausible FY27 recovery. Back-order book of £82.1m (+64% YoY) and new-customer pipeline at a record £271m provide multi-year revenue visibility; the £42.5m Omantel contract alone is the largest in the company's history 2026-06 interim results.
  2. Fortress balance sheet and shareholder-friendly capital returns. Net cash of £32.5m against a £207m market cap, zero meaningful debt, consistent ~17% annual dividend growth across the period, and discretionary buybacks demonstrate durable financial health through the downturn 2025-11 final results; 2026-06 interim results.
  3. Spectacular operating leverage will work in reverse during an upswing. Software licence revenue carries 80%+ gross margin; when revenue was growing 20–25% during FY21–FY23, adjusted EBITDA grew 31–81% YoY, with adjusted PBT rising 131% in FY21 alone 2023-11 final results. If the deferred FY26 orders simply slip into FY27, the margin snap-back could be dramatic.

Key risks

  1. Delayed orders may not fully return — contract timing is now the central question. Management attributed the FY26 shortfall to "delayed or deferred" orders including "software licence expansions and upgrades" 2026-09 full-year trading update, but there is no visibility into whether these are competitive losses, budget cuts at telco customers, or genuinely timing-related.
  2. Customer concentration and large-contract lumpiness. Customer No. 1 contributed £13.1m (29% of FY25 revenue) and Omantel will become similarly large; project-driven licence revenue creates significant period-on-period volatility, as the −38% H1 2026 EBITDA swing demonstrates 2025-11 final results; 2026-06 interim results.
  3. AI substitution risk is real at the margin, even if management disputes it. Management devoted an unusual amount of H1 2026 narrative to defending why telcos won't in-source BSS/OSS using AI tools 2026-06 interim results, which itself signals that the question is being asked by investors and customers; competitive pressure from AI-assisted builds by larger vendors (e.g. Amdocs) is a tangible risk.

Operating leverage

Cerillion exhibits textbook high operating leverage, and the FY20–FY25 record is one of the clearer examples on AIM. Gross margins run 78–81% 2024-11 final results; 2025-11 final results with the bulk of the cost base — R&D, central ops, management — essentially fixed. Services revenue carries lower margins but incremental software-licence revenue drops almost entirely to EBITDA; this is why FY21 revenue growth of 25% translated into a 131% adjusted PBT increase and 1,240bps of EBITDA margin expansion. Working the other way, H1 2026 revenue fell 14% but adjusted EBITDA fell 38% and EBITDA margin compressed 1,320bps to 34.5% 2026-06 interim results — the same leverage, inverted. The implication for a 10–20% revenue beat above management's current £46–48m FY26 guide is substantial: at the FY25 incremental margin pattern, each additional £1m of licence revenue could add £0.7–0.9m to EBITDA, meaning a £5–10m revenue surprise would plausibly expand EBITDA by £3.5–8m (an uplift of 15–40% on the guided FY26 base). The strategic footprint (India + Bulgaria operations) means fixed-cost expansion is being spread across lower-cost geographies, suggesting incremental margin could even exceed historical norms as the business re-scales.

Value-trap signals

  • Modest signal: FY26 is the first reported year of revenue growth decelerating meaningfully (from +12% in FY24 to flat/slightly down), accompanied by a visible profit warning.
  • Modest signal: Louis Hall (CEO, founder) sold £20m of stock via secondary placing at 1,500p in June 2025 — just months before the de-rating 2025-06 proposed secondary placing. He is subject to a 365-day lock-up but the timing in hindsight was prescient.
  • No evidence of: declining revenue trend (still growing), rising debt, dividend cuts (dividend +15% in H1 2026 despite earnings decline), aggressive accounting (clean audit reports, strong cash conversion historically), related-party issues, or regulatory threats. No structural value-trap signals identified.

Earnings vs. expectations

Across the five-year window, Cerillion built a track record of consistent beats: FY20 and FY21 trading updates flagged results "ahead of market expectations"; FY22's October trading update stated adjusted PBT would be "materially ahead" of £10.1m consensus (actual £11.9m); FY23's October trading update stated results would be "meaningfully ahead" of £14.3m consensus (actual £16.8m); FY24's October 2024 update flagged results "comfortably ahead" of £17.9m consensus (actual £19.8m); FY25 trading update was "slightly ahead" of consensus £20.5m (actual £21.8m). This long sequence of beats broke abruptly in September 2026 with a material miss (FY26 revenue £46–48m vs. consensus £52.8m, EBITDA margin 43–45% vs. 45.2%) 2026-09 full-year trading update. Pattern: five consecutive years of modest-to-meaningful beats, broken by one material miss driven by order deferrals.

Conviction: 3 (moderate)

Anchors: (a) exceptionally clean, well-disclosed financials across five years with consistent definitions; (b) proven and durable margin structure makes mid-cycle normalisation estimates well-grounded; (c) record back-order book provides a tangible floor on near-term revenue.

Limiters: (a) the FY26 profit warning materially changes the trajectory and we cannot yet verify whether deferred orders are truly timing-related or indicative of a structural slowdown; (b) telco customer buying behaviour and macro backdrop in FY27 is the single swing factor on fair value, and we have little visibility beyond management's commentary.


Filings consulted · 39

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-09-14Full Year Trading Update2026-09-14_9769035_full-year-trading-update.md0.85
  2. 2026-06-01Interim Results2026-06-01_9593199_interim-results.md0.90
  3. 2026-05-19Interim Results Investor Presentation2026-05-19_9574289_interim-results-investor-presentation.md0.90
  4. 2026-04-22H1 Trading Update2026-04-22_9531469_h1-trading-update.md0.85
  5. 2026-04-14Cfo Joining Date And Date OF Trading Update2026-04-14_9517990_cfo-joining-date-and-date-of-trading-update.md0.85
  6. 2026-02-19Result OF Agm2026-02-19_9438973_result-of-agm.md0.26
  7. 2026-01-12Posting OF Report And Accounts Amp Notice OF Agm2026-01-12_9347374_posting-of-report-and-accounts-amp-notice-of-agm.md0.26
  8. 2025-11-24Final Results2025-11-24_9251848_final-results.md0.85
  9. 2025-11-03Notice OF Final Results2025-11-03_9207502_notice-of-final-results.md0.85
  10. 2025-10-23Full Year Trading Update2025-10-23_9188402_full-year-trading-update.md0.72
  11. 2025-06-11Proposed Secondary Placing2025-06-11_8925016_proposed-secondary-placing.md0.46
  12. 2025-05-19Interim Results2025-05-19_8883715_interim-results.md0.58
  13. 2025-05-12Notice OF Results And Investor Presentation2025-05-12_8871613_notice-of-results-and-investor-presentation.md0.46
  14. 2025-04-14Half Year Trading Update2025-04-14_8828218_half-year-trading-update.md0.58
  15. 2025-02-13Result OF Agm2025-02-13_8736232_result-of-agm.md0.20
  16. 2024-12-13Posting OF Annual Report And Notice OF Agm2024-12-13_8610694_posting-of-annual-report-and-notice-of-agm.md0.62
  17. 2024-11-18Final Results2024-11-18_8555131_final-results.md0.65
  18. 2024-11-14Date OF Final Results And Online Presentation2024-11-14_8548962_date-of-final-results-and-online-presentation.md0.65
  19. 2024-10-21Trading Update2024-10-21_8497306_trading-update.md0.55
  20. 2024-05-13Investor Presentation2024-05-13_8190878_investor-presentation.md0.32
  21. 2024-05-13Interim Results2024-05-13_8190790_interim-results.md0.41
  22. 2024-04-22Trading Update2024-04-22_8148147_trading-update.md0.38
  23. 2024-02-01Result OF Agm2024-02-01_8018329_result-of-agm.md0.14
  24. 2023-12-15Posting OF Annual Report And Notice OF Agm2023-12-15_7945714_posting-of-annual-report-and-notice-of-agm.md0.43
  25. 2023-11-20Final Results2023-11-20_7890458_final-results.md0.45
  26. 2023-10-16Trading Update2023-10-16_7817592_trading-update.md0.38
  27. 2023-05-15Half Year Report2023-05-15_7526000_half-year-report.md0.23
  28. 2023-05-04Date OF Interim Results And Investor Presentation2023-05-04_7511990_date-of-interim-results-and-investor-presentation.md0.23
  29. 2023-04-17H1 2023 Trading Update2023-04-17_7491689_h1-2023-trading-update.md0.21
  30. 2023-02-02Result OF Agm2023-02-02_7354168_result-of-agm.md0.07
  31. 2022-11-28Final Results2022-11-28_7216610_final-results.md0.25
  32. 2022-11-23Notice OF Results And Investor Presentation2022-11-23_7456041_notice-of-results-and-investor-presentation.md0.17
  33. 2022-10-24Trading Update2022-10-24_7431144_trading-update.md0.21
  34. 2022-05-09Interim Results Presentation2022-05-09_7197104_interim-results-presentation.md0.23
  35. 2022-05-09Interim Results2022-05-09_7196986_interim-results.md0.23
  36. 2022-04-19H1 2022 Trading Update2022-04-19_6983974_h1-2022-trading-update.md0.21
  37. 2022-02-04Result OF Agm2022-02-04_6746526_result-of-agm.md0.07
  38. 2021-11-22Final Results2021-11-22_6835621_final-results.md0.25
  39. 2021-10-04Trading Update2021-10-04_6648489_trading-update.md0.09

This research note was authored by a large language model after reading 36 regulatory filings published between 2021-10-04 and 2026-09-14. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.